Through direct targeting of Smad4, miR-26a inhibits the nuclear translocation of p-Smad3, thereby blocking TGF-β1 downstream signal transduction and mitigating pulmonary fibrosis (Liang et al., 2014a). The gene discussed is SMAD3; the disease is pulmonary fibrosis.